Ono Partners with Congruence for Oncology Drug Discovery
05 Dec 2024 //
PR NEWSWIRE
Congruence, Ono Partner for Cancer Small Molecule Correctors
03 Dec 2024 //
PR NEWSWIRE
Congruence Appoints Experienced Drug Developer Michael as CDO
06 May 2024 //
PR NEWSWIRE